Research Capital initiated coverage of Auxly Cannabis Group (TSX:XLY) with a “buy” rating and price target of 50 cents (Canadian). The stock closed at 23 cents on Sept. 29. Auxly’s strategy to focus on building the...
Research Capital initiated coverage of Aleafia Health (TSX:AH) with a “buy” rating and price target of 75 cents (Canadian). The stock closed at 36 cents on Sept. 21. “We believe that Aleafia’s revenue growth will be...